Anti‐Saccharomyces cerevisiae mannan antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans

Background: Anti‐Saccharomyces cerevisiae antibodies (ASCA) present in a subgroup of Crohn's disease (CD) patients indicate loss of tolerance against commensal antigens. ASCA can be induced in Candida albicans‐infected rabbits, suggesting their potential crossreactive nature. The present study aimed to determine crossreactivities of ASCA with cell wall mannans from other yeasts, including the opportunistic pathogen C. albicans, and to define the requirements for (crossreactive) ASCA in experimental mice. Methods: ASCA were determined by enzyme‐linked immunosorbent assay (ELISA). ASCA were neutralized by preincubating sera with purified mannans. Binding of ASCA was visualized by Western blot. Mice were immunized with live yeasts and experimental colitis was induced with dextran sodium sulfate (DSS). Results: Seroreactivity of ASCA‐positive CD patients against S. cerevisiae mannan significantly correlates with that against mannans from 5 other yeast species, including C. albicans. This correlation is due to crossreactive IgG, demonstrated by the loss of reactivity after preincubation of sera with mannans from the other yeasts. Immunization of mice with S. cerevisiae or C. albicans fails to induce (crossreactive) ASCA IgM or IgG antibodies. Subsequent chronic experimental colitis concomitant with feeding live yeasts promotes ASCA IgM but not IgG generation, while titers remain modest compared to those in ASCA‐positive CD patients. Conclusions: Correlations of ASCA reactivities against mannans from different yeasts are due to crossreactive IgGs. The inability of mice to readily generate ASCA is in line with the current opinion that genetic predisposition is a prerequisite for the development of this and other unusual immune reactivities in CD.

[1]  D. Poulain,et al.  Comparative analysis of cell wall surface glycan expression in Candida albicans and Saccharomyces cerevisiae yeasts by flow cytometry. , 2006, Journal of immunological methods.

[2]  J. Mallet,et al.  Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. , 2006, Gastroenterology.

[3]  F. Seibold,et al.  Anti-Saccharomyces cerevisiae antibody titers are stable over time in Crohn's patients and are not inducible in murine models of colitis. , 2005, World journal of gastroenterology.

[4]  M. Aigle,et al.  Molecular genetic study of introgression between Saccharomyces bayanus and S. cerevisiae , 2005, Yeast.

[5]  R. Balicer,et al.  Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease , 2005, Gut.

[6]  J. Belisle,et al.  Export-Mediated Assembly of Mycobacterial Glycoproteins Parallels Eukaryotic Pathways , 2005, Science.

[7]  K. Takegawa,et al.  Characterization of O-mannosyltransferase family in Schizosaccharomyces pombe. , 2005, Biochemical and biophysical research communications.

[8]  F. Seibold,et al.  Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease. , 2004, Gastroenterology.

[9]  D. Jewell,et al.  The contribution of HLA genes to IBD susceptibility and phenotype. , 2004, Best practice & research. Clinical gastroenterology.

[10]  F. Seibold,et al.  Immune Sensitization to Yeast Antigens in ASCA-positive Patients with Crohn’s Disease , 2004, Inflammatory bowel diseases.

[11]  T. Kozel,et al.  Biological Activities of Naturally Occurring Antibodies Reactive with Candida albicans Mannan , 2004, Infection and Immunity.

[12]  G. Mitterdorfer,et al.  Clustering of Saccharomyces boulardii strains within the species S. cerevisiae using molecular typing techniques , 2002, Journal of applied microbiology.

[13]  A. Otter,et al.  The Unique Solution Structure and Immunochemistry of theCandida albicans β-1,2-Mannopyranan Cell Wall Antigens* 210 , 2002, The Journal of Biological Chemistry.

[14]  M. Scheurlen,et al.  Anti-Saccharomyces cerevisiae Antibodies in Inflammatory Bowel Disease: a Family Study , 2001, Scandinavian journal of gastroenterology.

[15]  D. McClish,et al.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  M. Gentzsch,et al.  Protein O-mannosylation. , 1999, Biochimica et biophysica acta.

[17]  J. Mccusker,et al.  Species Identification and Virulence Attributes ofSaccharomyces boulardii (nom. inval.) , 1998, Journal of Clinical Microbiology.

[18]  K. Ziegelbauer,et al.  Multiple Functions of Pmt1p-mediated ProteinO-Mannosylation in the Fungal Pathogen Candida albicans * , 1998, The Journal of Biological Chemistry.

[19]  L. Kasper,et al.  Some Opportunistic Parasitic Infections in AIDS: Candidiasis, Pneumocystosis, Cryptosporidiosis, Toxoplasmosis. , 1998, Parasitology today.

[20]  S. Suzuki.  Immunochemical study on mannans of genus Candida. I. Structural investigation of antigenic factors 1, 4, 5, 6, 8, 9, 11, 13, 13b and 34. , 1997, Current topics in medical mycology.

[21]  S. Suzuki,et al.  Amended structure of side chains in a cell wall mannan from Candida albicans serotype A strain grown in yeast extract-Sabouraud liquid medium under acidic conditions: detection of the branched side chains corresponding to antigenic factor 4. , 1997, FEMS microbiology letters.

[22]  D. M. Lupan,et al.  Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans , 1996, Infection and immunity.

[23]  P. Jacquinot,et al.  Specific antibody response to oligomannosidic epitopes in Crohn's disease , 1996, Clinical and diagnostic laboratory immunology.

[24]  S. Misbah,et al.  A comparison of specific IgG antibody levels to the cell wall mannan of Candida albicans in normal individuals and in patients with primary antibody deficiency. , 1992, Journal of immunological methods.

[25]  J. Main,et al.  Antigenic heterogeneity of strains of Saccharomyces cerevisiae and Candida albicans recognised by serum antibodies from patients with Crohn's disease. , 1992, FEMS microbiology immunology.

[26]  M. Sogin,et al.  Evolutionary relationships among pathogenic Candida species and relatives , 1991, Journal of bacteriology.

[27]  M. Kerr,et al.  Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. , 1988, BMJ.

[28]  J. Jones.  Quantitation of antibody against cell wall mannan and a major cytoplasmic antigen of Candida in rabbits, mice, and humans , 1980, Infection and immunity.

[29]  E. Reiss,et al.  Comparison by Elisa of serum anti-Candida albicans mannan IgG levels of a normal population and in diseased patients , 1980, Mycopathologia.

[30]  T. Nakase,et al.  Serologic aspects on yeast classification , 1974, Mycopathologia et mycologia applicata.

[31]  C. Ballou,et al.  Method for Fingerprinting Yeast Cell Wall Mannans , 1969, Journal of Bacteriology.